Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Arlington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Eloxx Pharmaceuticals, Inc. has filed 1,350 SEC EDGAR filings since 27 Mar 1997

SEC filing history

Showing 726-750 of 917 matching filings.

Per page
25
Current page
30
4

4 filing

Filing date
13 Apr 2012
Reporting date
15 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-31326

CT ORDER filing

Filing date
12 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Mar 2012
Reporting date
29 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-56243

SC 13G

Filing date
19 Mar 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
12 Mar 2012
Reporting date
12 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
07 Mar 2012
Reporting date
05 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-170140

424B5

Filing date
02 Mar 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K filing

Filing date
02 Mar 2012
Reporting date
01 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K

Filing date
01 Mar 2012
Reporting date
28 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
24 Feb 2012
Reporting date
16 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
24 Feb 2012
Reporting date
16 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
24 Feb 2012
Reporting date
16 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
24 Feb 2012
Reporting date
16 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
24 Feb 2012
Reporting date
16 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
24 Feb 2012
Reporting date
16 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
24 Feb 2012
Reporting date
16 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K

Filing date
15 Feb 2012
Reporting date
15 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

CURRENT REPORT

Filing date
14 Feb 2012
Reporting date
08 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-56243

SC 13D/A filing

Filing date
19 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 Jan 2012
Reporting date
06 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 Jan 2012
Reporting date
06 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-170140

424B5 filing

Filing date
09 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-170140

FREE WRITING PROSPECTUS

Filing date
09 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

CURRENT REPORT

Filing date
09 Jan 2012
Reporting date
06 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .